That's totally possible. In fact tumor growth slowing and tumor reduction didn't actually happen in mice until they received much higher doses than the first several cohorts. I'll be happy just to here news on p53 activation via the p21 marker at some point from this current study. I'm also slightly miffed we haven't heard the results from the blood tests on cohort one. I would have expected that news prior to the start of cohort 2.